Navigation Links
DNASequencing.com and a Portfolio of 318 'Genetic' Domain Names to be Auctioned Off at Epik.com Domain Development Conference
Date:9/14/2010

se wanting to submit a proxy bid for the domain and website auction can contact Epik.com directly for more information and instructions. The auction is managed by Moniker® (www.moniker.com) and SnapNames® (www.snapnames.com), both Oversee.net® companies and providers of domain name registration, management, monetization, and brokerage services. Bidders can follow the auction live and, bid online or in person. Conference details can be found at: http://www.Epik.com/conf.

About Epik.com

Epik.com was founded in 2009 with a simple goal – to help domain investors evolve from a singular dependence on domain parking to a more diversified array of value creation strategies that unlock the potential associated with an intuitive domain name. Epik.com is based in Seattle and is a leading provider of managed solutions for domain investing serving the needs of individuals and institutions that seek exposure to the domain name asset class.

http://www.Epik.com

http://www.Twitter.com/EpikDotCom

http://www.Facebook.com/EpikDotCom

http://www.YouTube.com/watch?v=Z2HwPgmcvEM


'/>"/>
SOURCE Epik.com
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Shire Proposes to Expand Specialist Gastrointestinal Portfolio
2. MacroGenics Receives NIH Grant Funding of $9.8M for Three Projects; Funding Further Advances DART Platform and Infectious Disease Portfolio
3. Silence Therapeutics Expands RNAi Structural Modification IP Portfolio With Issuance of New U.S. Patent
4. QIAGEN Acquires Comprehensive Portfolio of Molecular Food Safety Tests
5. Regado Biosciences, Inc. Continues to Expand Its Patent Portfolio By Announcing Issuance of a New Patent for Its Product Candidates, the REG1 and REG2 Anticoagulation Systems
6. Mendel Announces US Miscanthus Field Trial Results: Second Year Data Demonstrate High-Yielding, Genetically Diverse Product Portfolio
7. Shires Replenished Portfolio Drives Excellent Quarterly Performance
8. Pepscan Signs Partnering Agreement With Immunovo for its Therapeutic Vaccine Portfolio
9. ClearTrial to Demonstrate How a Top 20 Sponsor Achieved -1 Percent Cost Variance Across Their $130M Clinical Portfolio at Major Industry Conference
10. EUCODIS Bioscience Receives EUR 2 Million Cash Injection to Enlarge Product Portfolio and Develop International Markets
11. New Industry Research Identifies "Operational Gap" in Clinical Trial Portfolio Management
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/22/2014)... , Dec. 22, 2014   Synthetic ... developer of pathogen-specific therapies for serious infections ... the microbiome, today announced positive topline safety ... clinical trial of SYN-004, the Company,s investigational ... Clostridium difficile (C. difficile) infection, ...
(Date:12/22/2014)... Dec. 22, 2014 GenomeDx Biosciences today announced ... Cancer Classifier, a genomic test for prostate cancer, was ... men managed by radical prostatectomy without adjuvant therapy. Although ... relatively uncommon, using tumor genomics to identify these men ... is an important advance. The study has been ...
(Date:12/22/2014)... December 22, 2014 ITRA Global, one ... occupiers of commercial real estate, has further expanded its ... in Perth and Brisbane, Western Australia, reports Mylinda Vick, ... , ITRA Global / ACORPP (Australian Corporate Property ... consultancy company providing property services to a wide range ...
(Date:12/19/2014)... Charm Sciences is pleased to announce that its ... M1 in raw commingled milk is the first lateral ... peer reviewed report of the validation by Technology and ... Fisheries Research (ILVO-T&V) has been published by the Taylor ... toxic aflatoxin and a known carcinogen, can be passed ...
Breaking Biology Technology:Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 2Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 3Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 4Synthetic Biologics Announces Positive Topline Results from Phase 1a Trial of SYN-004 for the Prevention of C. difficile Infection 5Study Published in European Urology Shows that the Decipher Prostate Cancer Classifier is Predictive of Rapid Metastasis in High-Risk Men who have had Prostate Surgery 2Study Published in European Urology Shows that the Decipher Prostate Cancer Classifier is Predictive of Rapid Metastasis in High-Risk Men who have had Prostate Surgery 3ITRA Global Continues International Expansion in Perth and Brisbane, Australia 2Charm Sciences Achieves Independent Validation of First 15 Minute Quantitative Screening Method for Aflatoxin M1 2
... 28 Memory,Pharmaceuticals Corp. (Nasdaq: MEMY ) today ... Qualifications Panel that the listing of the,Company,s common stock ... NASDAQ Capital Market effective with the opening of trading ... trade under the ticker,"MEMY.", The Panel has also ...
... gene-expression system at the ... conference, booth ... pioneer in,the development of cost-effective, easy-to-use gene-expression analysis,systems, announced that ... a professor in the Department of,Biochemistry and Molecular Biology at ...
... global clinical,research organization, announced that it is a ... in the "Best Contract Research Organization",category. The winners ... awards,ceremony on December 10, at the London Hilton ... Chiltern made the shortlist for this esteemed,award," commented ...
Cached Biology Technology:Memory Pharmaceuticals Provides Update on NASDAQ Listing Status 2Memory Pharmaceuticals Provides Update on NASDAQ Listing Status 3James L. Wittliff, Ph.D., FACB, to Present 'Predicting Breast Cancer Outcome with Gene Expression Signatures on the Ziplex(R) System' at the Association for Molecular Pathology Conference, October 30 2James L. Wittliff, Ph.D., FACB, to Present 'Predicting Breast Cancer Outcome with Gene Expression Signatures on the Ziplex(R) System' at the Association for Molecular Pathology Conference, October 30 3Chiltern Is a Nominee on the SCRIP CRO of the Year Award Shortlist 2
(Date:12/10/2014)... California , December 9, 2014 ... with ITN,s BCARD Platform   ... cloud-based enterprise meeting scheduling solutions for business-to-business (B2B) ... the world leader in mobile near-field communication (NFC), ...      (Logo: http://photos.prnewswire.com/prnh/20140612/691055) , ...
(Date:12/3/2014)... IRVINE, Calif. , Dec. 2, 2014 /PRNewswire/ ... of globally deployed, innovative test solutions for military, ... the newest version of its successful TS-900 ... the performance and features of high-end systems to ... with outstanding value compared to traditional ATE. ...
(Date:11/21/2014)... Strict laws against distracted driving and the ... American and European automotive sector towards gesture recognition technologies. ... that are intuitive and able to retrieve information with ... New analysis from Frost & Sullivan,s Strategic ... Europe and North America ...
Breaking Biology News(10 mins):Jifflenow And ITN International Bring Cutting-Edge Badge Scanning Technology To B2B Events 2Jifflenow And ITN International Bring Cutting-Edge Badge Scanning Technology To B2B Events 3Marvin Test Solutions Brings New Capabilities to PXI-Based Semiconductor Test with TS-960 2Marvin Test Solutions Brings New Capabilities to PXI-Based Semiconductor Test with TS-960 3Gesture Recognition Intensifies with the Rise of In-car Smartphone Integration, Says Frost & Sullivan 2Gesture Recognition Intensifies with the Rise of In-car Smartphone Integration, Says Frost & Sullivan 3Gesture Recognition Intensifies with the Rise of In-car Smartphone Integration, Says Frost & Sullivan 4
... Hyperhomocysteinemia and abnormal blood lipids are independent risk factors for ... the onset of stroke remains unclear. As reported in the ... a study by Dr. Xiaoyong Sai and colleagues from Chinese ... a 5 year period from the Chinese PLA General Hospital, ...
... Global average temperatures will rise at least 4C by 2100 ... emissions are not reduced according to new research published in ... to carbon dioxide than most previous estimates. , The research ... climate sensitivity, the role of cloud formation and whether this ...
... poplar trees in Zwijnaarde, Belgium, shows that the wood of ... a more efficient way. These sugars can serve as the ... The results of the field trial have been published ... field trial of French colleagues of the INRA institute in ...
Cached Biology News:Cloud mystery solved: Global temperatures to rise at least 4°C by 2100 2Field trial with lignin modified poplars shows potential for bio-based economy 2
... ultimate in utility and flexibility press-to-seal silicone ... needs of the researcher. They are available ... as sheet material that can be easily ... are autoclavable and non-cytotoxic and can be ...
Argon Calibration Source...
SHEEP ANTI ESCHERICHIA COLI...
Recombinant Rat Leptin, CF...
Biology Products: